Canadian Bioceutical teams up with Israeli-based Panaxia

Canadian Bioceutical continues to work on getting its own licence here in Canada to produce marijuana. In the meantime, the firm has teamed up in a joint-venture with Israeli-based Panaxia, which develops pharma-grade cannabis products. The company has actually delisted from the venture onto the CSE in order to invest in U.S. assets.

Related Posts

Leave A Reply